Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Rowena C. Punzalan MD

Rowena C. Punzalan MD

Associate Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Hematology


  • A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. (Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS) Artif Organs 2016 Jan;40(1):80-5 PMID: 26620919 12/02/2015
  • Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*. (Schloemer NJ, Abu-Sultaneh S, Hanson SJ, Yan K, Hoffmann RG, Punzalan RC, Havens PL) Pediatr Crit Care Med 2014 Sep;15(7):e294-9 PMID: 24901803 06/06/2014
  • The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. (Rangarajan HG, Punzalan RC, Camitta BM, Talano JA) Br J Haematol 2013 Nov;163(3):357-64 PMID: 23961954 08/22/2013
  • Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion. (Collins CL, Scott JP, Panepinto JA, Punzalan RC) J Pediatr Hematol Oncol 2013 Jul;35(5):e226-8 PMID: 23459377 PMCID: PMC4508016 03/06/2013
  • Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurement. (Franzblau EB, Punzalan RC, Friedman KD, Roy A, Bilen O, Flood VH) Pediatr Blood Cancer 2013 Mar;60(3):500-2 PMID: 23129109 PMCID: PMC4461026 11/07/2012
  • Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. (Hanson SJ, Punzalan RC, Arca MJ, Simpson P, Christensen MA, Hanson SK, Yan K, Braun K, Havens PL) J Trauma Acute Care Surg 2012 May;72(5):1292-7 PMID: 22673257 06/08/2012
  • Incidence and risk factors for venous thromboembolism in critically ill children with cardiac disease. (Hanson SJ, Punzalan RC, Christensen MA, Ghanayem NS, Kuhn EM, Havens PL) Pediatr Cardiol 2012 Jan;33(1):103-8 PMID: 21927987 09/20/2011
  • Trimethoprim-induced immune hemolytic anemia in a pediatric oncology patient presenting as an acute hemolytic transfusion reaction. (Gupta S, Piefer CL, Fueger JT, Johnson ST, Punzalan RC) Pediatr Blood Cancer 2010 Dec 01;55(6):1201-3 PMID: 20589632 07/01/2010
  • Incidence and risk factors for venous thromboembolism in critically ill children after trauma. (Hanson SJ, Punzalan RC, Greenup RA, Liu H, Sato TT, Havens PL) J Trauma 2010 Jan;68(1):52-6 PMID: 20065757 01/13/2010
  • Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation. (Niebler RA, Punzalan RC, Marchan M, Lankiewicz MW) Pediatr Crit Care Med 2010 Jan;11(1):98-102 PMID: 19561557 06/30/2009
  • Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass. (Hanson SJ, Punzalan RC, Ghanayem N, Havens P) Pediatr Crit Care Med 2007 Jul;8(4):358-61 PMID: 17545932 06/05/2007
  • Erythrocyte adhesion is modified by alterations in cellular tonicity and volume. (Wandersee NJ, Punzalan RC, Rettig MP, Kennedy MD, Pajewski NM, Sabina RL, Paul Scott J, Low PS, Hillery CA) Br J Haematol 2005 Nov;131(3):366-77 PMID: 16225657 10/18/2005
  • Concurrent poststreptococcal glomerulonephritis and autoimmune hemolytic anemia. (Greenbaum LA, Kerlin BA, Van Why S, Punzalan RC, Trost BA, Pan CG, Scott JP) Pediatr Nephrol 2003 Dec;18(12):1301-3 PMID: 14586676 10/31/2003
  • Low-molecular-weight heparin in thrombotic disease in children and adolescents. (Punzalan RC, Hillery CA, Montgomery RR, Scott CA, Gill JC) J Pediatr Hematol Oncol 2000 Mar-Apr;22(2):137-42 PMID: 10779027 04/25/2000
  • Last update: 12/06/2016
    jenkins-FCD Prod-38 cbde4bce27d896c78ced066bd23fa5cbe01e29f9